Results 21 to 30 of about 15,281 (191)
Current Treatment Options in Cardiovascular Medicine, 2007 In patients with carcinoid heart disease, a multidisciplinary approach to patient care is required because treatment of the systemic disease and management of cardiac involvement must be considered at the same time. Somatostatin analogue use is a therapeutic cornerstone, effective in symptomatic control of the endocrine syndrome.
Alain M, Bernheim +2 more
+7 more sources
Overall survival based on risk prediction scores after cardiac surgery in carcinoid heart disease. [PDF]
JTCVS OpenAlabdaljabar MS +6 more
europepmc +2 more sources
Carcinoid heart disease: [PDF]
European Heart Journal, 2015 A 72-year-old gentleman presented with right heart failure (RHF) from tricuspid insufficiency. He also noted episodes of diarrhoea and flushing. Echocardiogram showed severe tricuspid regurgitation (TR) with thickened tricuspid leaflets ( Panel A ).
Dashwood, Alexander +2 more
openaire +4 more sources
Journal of Medical Case Reports, 2022 Background Carcinoid heart disease is the cardiac manifestation of carcinoid syndrome. There is limited research on rhythm management in patients with carcinoid heart disease.
Susann Groschke +6 more
doaj +1 more source
A forgotten diagnosis in right heart failure: A case report and literature review
Clinical Case Reports, 2021 Carcinoid heart disease is a well‐known complication of carcinoid syndrome that affects morbidity and mortality. Carcinoid heart disease may be asymptomatic in the early stages; therefore, patients with carcinoid syndrome should be screened to prevent ...
Azin Alizadehasl +5 more
doaj +1 more source
Current Cardiology Reports, 2006 Progress in the medical and surgical management of patients with carcinoid disease has resulted in improved symptoms and survival. Carcinoid heart disease remains a major cause of morbidity and mortality among patients with malignant carcinoid syndrome.
Heidi M, Connolly, Patricia A, Pellikka
+5 more sources
JACC: Case Reports, 2020 Carcinoid heart disease is a complication of carcinoid syndrome. The role of selective serotonin reuptake inhibitors in carcinoid heart disease is unclear. We present a case of refractory heart failure due to right- and left-sided carcinoid heart disease
Jennifer Bell, MD +4 more
doaj +1 more source
Brazilian Journal of Cardiovascular Surgery, 2021 Carcinoid tumors can be a cause for right heart valve disease, also known as Hedinger syndrome or carcinoid heart disease. Proper understanding of the pathophysiology is of the uttermost importance for adequate treatment of these patients, especially ...
Albert Franz Guerrero-Becerra +4 more
doaj +1 more source
Outcome of carcinoid heart syndrome in patients enrolled in the SwissNet cohort
BMC Cancer, 2023 Background Carcinoid heart disease is a rare disease which develops in patients with functional neuroendocrine tumors in an advanced tumor state. Patients diagnosed with carcinoid heart disease have a poor longtime prognosis with respect to morbidity and
Eva Grundmann +3 more
doaj +1 more source